Discover how Akero Therapeutics' EFX outshines competitors in MASH treatment, with groundbreaking results and strong ...

Corebridge Financial Inc. lowered its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 7.0% in ...

American Century Companies Inc. lifted its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 55.1 ...

In trading on Tuesday, shares of Akero Therapeutics Inc (Symbol: AKRO) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $38.98 per share. By ...

NEW YORK CITY, NY / ACCESS Newswire / March 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the Company ...

On Thursday, Akero Therapeutics', G. Walmsley Graham, made a $8.79M buy of AKRO, purchasing 200,000 shares at a cost of $43.94 a piece. Akero Therapeutics is trading down about 0.7% on the day Friday.

"Today, we're not connected enough with nature," explains Olivier Cresp, a master perfumer and co-founder of the fragrance brand Akro. "These [more radically] nature-inspired scents are a form of ...

NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

I’ll admit that I was initially skeptical. But it didn't take long for this tiny, portable model to win me over.

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge ...